Nepal government has decided to procure four million Covid-19 vaccines manufactured by China’s Sinopharm under a non-disclosure agreement
The Nepal government has decided to procure four million Covid-19 vaccines manufactured by China’s Sinopharm under a non-disclosure agreement. However, the government has not disclosed the price of the vaccine. Since it is to be signed under a non-disclosure agreement, there is no provision of making public the rate of each dose, a senior Nepal government official told IANS. During a meeting of Covid Crisis Management Centre on Wednesday, Prime Minister KP Sharma Oli said the vaccines were expected to arrive by the end of June. Nepali media have speculated the price of the vaccines to be between $18 to $21 for two doses.
Meanwhile, Deputy Prime Minister and Minister for Foreign Affairs, Raghubir Mahaseth confirmed the government’s decision to buy the Chinese vaccines developed by Sinopharm which were earlier branded as Verocell. Nepal is currently using Verocell after China donated 1.8 million doses earlier as a grant assistance.
Similarly Nepal also received 1 million Covishield vaccines from India as a grant in January and procured another 2 million from the Serum Institute of India (SII) and paid the full money in advance. Out of that 2 million Covid vaccines that were procured from SII, Nepal has already received one million vaccines on February 21. But the Himalayan nation could not get rest 1 million after India put a ban on vaccine export.

Comments
Post a Comment